News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
507,786 Results
Type
Article (29997)
Company Profile (162)
Press Release (477627)
Multimedia
Podcasts (45)
Webinars (8)
Section
Business (138970)
Career Advice (543)
Deals (23441)
Drug Delivery (53)
Drug Development (83426)
Employer Resources (52)
FDA (13850)
Job Trends (10367)
News (258483)
Policy (21860)
Tag
Academia (1939)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (84)
Alliances (38519)
ALS (98)
Alzheimer's disease (1415)
Antibody-drug conjugate (ADC) (139)
Approvals (13844)
Artificial intelligence (248)
Autoimmune disease (25)
Automation (13)
Bankruptcy (182)
Best Places to Work (8860)
BIOSECURE Act (13)
Biosimilars (75)
Biotechnology (119)
Bladder cancer (85)
Brain cancer (31)
Breast cancer (283)
Cancer (2292)
Cardiovascular disease (188)
Career advice (479)
Career pathing (15)
CAR-T (161)
Cell therapy (423)
Cervical cancer (20)
Clinical research (69175)
Collaboration (775)
Compensation (406)
Complete response letters (27)
COVID-19 (2348)
CRISPR (37)
C-suite (213)
Cystic fibrosis (95)
Data (2197)
Decentralized trials (2)
Denatured (16)
Depression (51)
Diabetes (246)
Diagnostics (5632)
Digital health (15)
Diversity (8)
Diversity, equity & inclusion (17)
Drug discovery (109)
Drug pricing (35)
Drug shortages (11)
Duchenne muscular dystrophy (94)
Earnings (52916)
Editorial (22)
Employer branding (4)
Employer resources (49)
Events (79427)
Executive appointments (622)
FDA (15028)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (672)
Gene editing (98)
Generative AI (25)
Gene therapy (298)
GLP-1 (663)
Government (2561)
Grass and pollen (4)
Guidances (52)
Healthcare (14852)
Huntington's disease (24)
IgA nephropathy (30)
Immunology and inflammation (123)
Indications (30)
Infectious disease (2485)
Inflammatory bowel disease (142)
Inflation Reduction Act (3)
Influenza (51)
Intellectual property (85)
Interviews (81)
IPO (11754)
IRA (14)
Job creations (1883)
Job search strategy (423)
Kidney cancer (11)
Labor market (18)
Layoffs (361)
Leadership (7)
Legal (3722)
Liver cancer (74)
Lung cancer (335)
Lymphoma (153)
Machine learning (5)
Management (17)
Manufacturing (225)
MASH (73)
Medical device (10439)
Medtech (10441)
Mergers & acquisitions (12201)
Metabolic disorders (638)
Multiple sclerosis (81)
NASH (21)
Neurodegenerative disease (104)
Neuropsychiatric disorders (31)
Neuroscience (1974)
NextGen: Class of 2025 (4438)
Non-profit (2917)
Now hiring (19)
Obesity (328)
Opinion (159)
Ovarian cancer (73)
Pain (91)
Pancreatic cancer (80)
Parkinson's disease (156)
Partnered (15)
Patents (189)
Patient recruitment (116)
Peanut (45)
People (41266)
Pharmaceutical (40)
Pharmacy benefit managers (1)
Phase I (21769)
Phase II (30549)
Phase III (22847)
Pipeline (1151)
Policy (54)
Postmarket research (2324)
Preclinical (7867)
Press Release (64)
Prostate cancer (112)
Psychedelics (35)
Radiopharmaceuticals (251)
Rare diseases (371)
Real estate (3500)
Recruiting (20)
Regulatory (17487)
Reports (24)
Research institute (2000)
Resumes & cover letters (72)
Rett syndrome (5)
RNA editing (4)
RSV (33)
Schizophrenia (75)
Series A (124)
Series B (83)
Service/supplier (11)
Sickle cell disease (43)
Special edition (12)
Spinal muscular atrophy (154)
Sponsored (20)
Startups (2601)
State (1)
Stomach cancer (13)
Supply chain (44)
Tariffs (13)
The Weekly (29)
Vaccines (640)
Venture capitalists (25)
Weight loss (199)
Women's health (31)
Worklife (6)
Date
Today (159)
Last 7 days (777)
Last 30 days (2284)
Last 365 days (29046)
2025 (9467)
2024 (31044)
2023 (35036)
2022 (43694)
2021 (46204)
2020 (43013)
2019 (34262)
2018 (25917)
2017 (26431)
2016 (24399)
2015 (28501)
2014 (20916)
2013 (16156)
2012 (17115)
2011 (17667)
2010 (16509)
Location
Africa (471)
Alabama (45)
Alaska (3)
Arizona (127)
Arkansas (10)
Asia (31356)
Australia (5850)
California (5490)
Canada (1613)
China (502)
Colorado (233)
Connecticut (242)
Delaware (129)
Europe (71925)
Florida (736)
Georgia (173)
Idaho (42)
Illinois (372)
India (22)
Indiana (239)
Iowa (6)
Japan (150)
Kansas (87)
Kentucky (23)
Louisiana (8)
Maine (25)
Maryland (694)
Massachusetts (4048)
Michigan (165)
Minnesota (269)
Mississippi (2)
Missouri (61)
Montana (27)
Nebraska (18)
Nevada (49)
New Hampshire (56)
New Jersey (1502)
New Mexico (22)
New York (1528)
North Carolina (877)
North Dakota (7)
Northern California (2425)
Ohio (161)
Oklahoma (13)
Oregon (31)
Pennsylvania (1225)
Puerto Rico (8)
Rhode Island (20)
South America (608)
South Carolina (19)
Southern California (2088)
Tennessee (77)
Texas (834)
United States (19938)
Utah (144)
Virginia (131)
Washington D.C. (41)
Washington State (483)
West Virginia (2)
Wisconsin (41)
507,786 Results for "worldwide clinical trials".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immunology and inflammation
Vyne Crashes After Safety Signal in Dogs Puts Hold on Clinical Trial of Plaque Psoriasis
The hold, placed by the FDA on an early-stage clinical trial of an experimental BET inhibitor, stems from a recent observation of testicular toxicity in canines given the treatment.
April 25, 2025
·
2 min read
·
Tristan Manalac
IN PARTNERSHIP WITH DIA
Balancing Protection and Inclusion: The Evolution of Women in Clinical Trials
In this episode presented by DIA, BioSpace’s head of insights Lori Ellis discusses the evolution of women’s inclusion in clinical trials with Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives at the National Academy of Medicine.
March 27, 2025
·
1 min read
·
Lori Ellis
Drug Development
Worldwide Clinical Trials Recognized as Highest Rated Phase I Provider for Overall User Preference in 2024 Industry Standard Research Phase I Benchmarking Report
Worldwide Clinical Trials (Worldwide), a global full-service contract research organization (CRO), proudly announces results of the 2024 Industry Standard Research (ISR) Phase I CRO Benchmarking Report.
June 25, 2024
·
4 min read
Press Releases
Next Generation Targeted Alpha Therapy Clinical Trials Development Insight
“Currently More Than 20 Targeted Alpha Therapies Are In Clinical Trials”
January 29, 2025
·
1 min read
Press Releases
Clearmind Medicine Launches First U.S. Clinical Site for its FDA-Approved Clinical Trial to Combat Alcoholism
April 16, 2025
·
6 min read
Press Releases
LIfT BioSciences announces partnership with University of Galway for clinical trial in Ireland
April 28, 2025
·
4 min read
Partnered
The APAC Opportunity: Why Clinical Trials Are Shifting East
APAC offers stability in an increasing challenging global geopolitical environment for clinical stage drug development.
February 3, 2025
·
7 min read
·
BioSpace Insights
Press Releases
Heart Disease Deaths Worldwide Linked to Chemical Widely Used in Plastics
April 29, 2025
·
6 min read
Press Releases
Ora Unveils Breakthrough Clinical Trial Innovations at ARVO 2025
May 1, 2025
·
5 min read
Business
Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12
Artelo Biosciences, Inc. today announced that it has selected Worldwide Clinical Trials to support the Company’s planned Phase 1 trial with ART26.12, its Fatty Acid Binding Protein 5 (FABP5) inhibitor in development for the treatment of chemotherapy-induced peripheral neuropathy (CIPN).
January 8, 2024
·
6 min read
1 of 50,779
Next
